8 results
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
: Age>60, CKD, CHF ... fluid balance, and CXR ... with pulmonary ... edema) • Fever ... Transfusion #Reactions #hematology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... and Culture • CXR ... Tuberculosis Treatment ... Initiating Treatment ... disease • Check CXR
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... and Culture • CXR ... Tuberculosis Treatment ... Initiating Treatment ... disease • Check CXR
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... myalgias, HoTN, edema ... - pulmonary opacities ... sepsis), PE, DAH, CHF ... diagnosis #management #hematology
On the left another patient with alveolar edema at admission, which resolved after treatment.
When you scroll
with alveolar edema ... resolved after treatment ... #Clinical #Radiology ... #CXR #CHF #Alveolar ... #Pulmonary #Edema
Stage III - Alveolar edema
This stage is characterized by continued fluid leakage into the interstitium, which
position Obstructive lung ... After treatment ... #Clinical #Radiology ... #CXR #CHF #Alveolar ... #Pulmonary #Edema
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... LVEDd > 6.0 cm, LV thrombus ... May have typical HF ... orthopnea, PND, LE edema ... management #cardiology #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... , INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... muscarinic agonists • Active